New virtual, innovative clinical trial for adults at high risk for respiratory illnesses
Kaiser Permanente researchers to study Vascepa in people 50 and older with heart disease.
Rebecca S. Boxer, MD, comments on COVID-19 clinical trial in nursing homes
In an interview with the New York Times, Rebecca Boxer, MD, discusses how a new clinical trial will serve a population greatly in need of targeted COVID-19 treatments.
Kaiser Permanente joins phase 3 clinical trial for COVID-19 vaccine
The late-stage clinical trial will test the vaccine in 1,400 adults at 4 sites in California and Oregon.
Living longer and better after cancer
Clinical trials play a vital role in advancing cancer treatment at Kaiser Permanente, improving patients’ survival and quality of life.
Permanente Medicine powers coordinated effort around remdesivir clinical research trials
Collaboration between Kaiser Permanente’s care delivery system and research programs has driven the successful implementation of remdesivir clinical trials across regions.
Advancing treatments through clinical trials
Kaiser Permanente’s clinical trials help advance treatment for health conditions and diseases ranging from heart disease and cancer to AIDS and COVID-19.
Kaiser Permanente research centers prioritize urgent COVID-19 research projects, clinical trials
In an effort to improve understanding and clinical practice guidelines around the novel coronavirus, Kaiser Permanente’s various research centers are quickly moving to investigate potential treatment for COVID-19.